The Role of COX-2 Expression in Locally Advanced Rectal Cancer Treated with Neoadjuvant Concurrent Radiation with Capecitabine/Oxaliplatin and Celecoxib

被引：0
|
作者：
Cai, G. [1 ]
Zhang, Z. [1 ]
Zhu, J. [1 ]
Gu, W. [1 ]
Zhang, S. [1 ]
Hu, Y. [1 ]
Li, G. [1 ]
Cai, S. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer
    Gao, Y. -H.
    Zhang, X.
    An, X.
    Cai, M. -Y.
    Zeng, Z. -F.
    Chen, G.
    Kong, L. -H.
    Lin, J. -Z.
    Wan, D. -S.
    Pan, Z. -Z.
    Ding, P. -D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (02) : 158 - 164
  • [32] Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer Treatment outcome outside clinical trials
    Winkler, J.
    Zipp, L.
    Knoblich, J.
    Zimmermann, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 377 - 382
  • [33] Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
    Leichman, Cynthia Gail
    McDonough, Shannon L.
    Smalley, Stephen R.
    Billingsley, Kevin G.
    Lenz, Heinz-Josef
    Beldner, Matthew A.
    Hezel, Aram F.
    Velasco, Mario R.
    Guthrie, Katherine A.
    Blanke, Charles D.
    Hochster, Howard S.
    CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E121 - E125
  • [34] Neoadjuvant Radiochemotherapy with Capecitabine and Oxaliplatin plus bevacizumab in locally advanced Rectal Cancer - Results of a phase II study
    Dellas, K.
    Hoehler, T.
    Riesenbeck, D.
    Reese, T.
    Wuerschtnidt, F.
    Engel, E.
    Roedel, C.
    Wagner, W.
    Richter, M.
    Dunst, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 51 - 51
  • [35] The role of COX-2 in rectal cancer treated with preoperative radiotherapy
    Hanifa Bouzourene
    Pu Yan
    Dominique Sandmeier
    Abderrahim Zouhair
    Maurice Matter
    Henri Vuilleumier
    Philippe Coucke
    Virchows Archiv, 2008, 452 : 499 - 505
  • [36] The role of COX-2 in rectal cancer treated with preoperative radiotherapy
    Bouzourene, Hanifa
    Yan, Pu
    Sandmeier, Dominique
    Zouhair, Abderrahim
    Matter, Maurice
    Vuilleumier, Henri
    Coucke, Philippe
    VIRCHOWS ARCHIV, 2008, 452 (05) : 499 - 505
  • [37] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Kathrin Dellas
    Thomas Höhler
    Thomas Reese
    Florian Würschmidt
    Erik Engel
    Claus Rödel
    Wolfgang Wagner
    Michael Richter
    Dirk Arnold
    Jürgen Dunst
    Radiation Oncology, 8
  • [38] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Dellas, Kathrin
    Hoehler, Thomas
    Reese, Thomas
    Wuerschmidt, Florian
    Engel, Erik
    Roedel, Claus
    Wagner, Wolfgang
    Richter, Michael
    Arnold, Dirk
    Dunst, Juergen
    RADIATION ONCOLOGY, 2013, 8
  • [39] Neoadjuvant Concurrent Chemoradiotherapy in Treating Locally Advanced Rectal Cancer
    Twu, Chia-Ming
    Wang, Hwei-Ming
    Chen, Joe-Bin
    Chao, Te-Hsin
    Mar, Hsiu-Feng
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2009, 72 (04) : 179 - 182
  • [40] Overexpression of COX-2 predicts poor response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma
    Taher, A.
    Roswell, C.
    Khalifa, M. A.
    Saad, R. S.
    LABORATORY INVESTIGATION, 2008, 88 : 137A - 137A
12345